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To the Editor: Infective endocarditis remains a life-threatening
disease. Platelets have an important role in the pathogenesis of
endocarditis (1) and are sensitive monitors of the systemic host
response to sepsis. We have investigated the platelet response in
infective endocarditis and its relationship to 6-month mortality.
We retrospectively reviewed consecutive cases of infective en-
docarditis admitted to Royal Prince Alfred Hospital (Sydney,
Australia) between 1996 and 2006 and identified 192 patients
meeting the modified Duke criteria for definite or possible endo-
carditis. Clinical and laboratory variables including those previ-
ously associated with adverse outcomes (2,3) were systematically
collected at presentation to the emergency department (day 1), and
at days 4, 8, and 12. Days 1 and 8 were pre-specified for detailed
analysis because average platelet survival is 8 days, and previous
studies have indicated that patient re-evaluation during treat-
ment and consideration for surgery are typically performed after
1 week (2).
The primary outcome of all-cause mortality at 6 months after
presentation was determined from medical records and the New
South Wales Registry of Births, Deaths, and Marriages and was
complete for 96.7% of patients. Patients with incomplete outcome
data were censored according to their status at the time of last
contact. Statistical comparisons were made using independent
samples t test, chi-square test, and Cox proportional hazards
regression models as indicated.
The clinical characteristics and outcomes of the cohort are
summarized (Online Table 1). The patients were young and
predominantly male. Left-sided infections were implicated in 78%
of patients and prosthetic valve infections in 19% of patients.
Blood cultures were positive in 83% of patients and Staphylococcus
aureus was the most common organism isolated. Cardiac surgery
was performed during the index admission in 30% of patients. The
all-cause 6-month mortality was 24%.
Platelet counts were significantly lower among nonsurvivors
than survivors at presentation (138.3  86.8  103/l vs. 196.3 
115.6  103/l; p  0.01), day 8 (177.2  105.5  103/l vs.
327.9  141.7  103/l; p  0.01) and throughout the first 12
days of admission (Online Fig. 1). The severity of thrombocyto-
penia predicted 6-month mortality (Fig. 1). Exclusion of patients
with pre-morbid thrombocytopenia (n 5; platelet count range 70
to 111  103/l) did not affect the analyses.
Similar platelet counts were observed in patients who were
medically treated (n 135) and in patients who underwent surgery
(n  57) at day 1 (182.6  114.1  103/l vs. 181.0  107.2 
103/l; p  0.93) and day 8 (304.2  149.1  103/l vs. 271.0 
140.8  103/l; p  0.16). Day 8 platelet counts were lower in
nonsurvivors than survivors regardless of whether they were med-
ically treated (190.7  111.9  103/l vs. 337.0  142.7 
103/l; p 0.001) or surgically treated (142.9 81.5 103/l vs.
303.8  134.3  103/l; p  0.001).
Infection with Staphylococcus aureus was associated with a lower
mean platelet count at day 1 compared to nonstaphylococcal
infections (134.7  107.8  103/l vs. 223.7  98.4  103/l;
p  0.001), but this association was not observed at day 8 (307.8 
172.3  103/l vs. 283.0  122.2  103/l; p  0.28). Older age,
comorbidity (Charlson score), renal impairment, and hypoalbumine-
mia were associated with lower day 8 platelet counts (p  0.05).
At day 1, the strongest univariate predictors of 6-month
mortality by Cox proportional hazards regression analysis (p 
0.01) were Charlson score 3, echocardiographic left ventricular
dysfunction, pulse rate, heart failure, and platelet count. At day 8,
the strongest predictors were Charlson score 3, echocardio-
graphic left ventricular dysfunction, heart failure, severe embolic
event, intracardiac abscess, nonsinus rhythm, white cell count,
platelet count, serum creatinine, and C-reactive protein.
Multivariate backward-stepwise Cox proportional hazards re-
gression analysis incorporated univariate associations with p 
0.10 and other previously reported associations (2,3) with mortality
with univariate p  0.10 (Online Table 2). At baseline, platelet
count (p 0.02), age (p 0.006), Charlson score3 (p 0.006),
pulse rate (p  0.001), congestive heart failure (p  0.004), and
serum creatinine (p  0.03) were independent predictors. At day
8, platelet count (p  0.001), congestive heart failure (p  0.01),
serum creatinine (p  0.04), and severe embolic event (p  0.002)
were independent predictors. One limitation of our models is the
relatively small number of events relative to the number of variables
fitted. This mandates confirmation of the models in independent
and larger cohorts.
To simplify its use as a clinical predictor, we assessed the relation-
ship between thrombocytopenia (platelet count 150  103/l) and
mortality. The incidence of thrombocytopenia was 45.1%, 33.3%,
16.2%, and 8.0% on days 1, 4, 8, and 12 respectively. Thrombocyto-
penia at presentation increased the odds of 6-month mortality
2.5-fold (95% confidence interval 1.3 to 4.6; p  0.004), and
thrombocytopenia at day 8 increased the odds 5.1-fold (95% confi-
dence interval 2.7 to 9.8; p  0.001).
Our study demonstrates that prognosis in infective endocarditis
is related to the timing and severity of thrombocytopenia. Serial
measurements of the platelet count may provide a simple means of
monitoring the evolution of disease and the patient response to
treatment in infective endocarditis.
Thrombocytopenia is likely to be a specific prognostic marker in
endocarditis rather than simply a surrogate marker for the acute
phase reaction. Platelets play an important role in the local host
defense against endovascular infections, and experimentally in-
duced thrombocytopenia is associated with more severe disease in
animal models (1). Consistent with this, we found thrombocyto-
penia to be an independent predictor of mortality at both day 1 and
8. In contrast, acute phase reactants such as C-reactive protein and
white cell count were univariate predictors of mortality but were
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not independently predictive on multivariate analysis. In addition,
there was no association between erythrocyte sedimentation rate
and mortality.
The finding of thrombocytopenia in patients with endocarditis
has clinical implications. First, patients presenting with thrombo-
cytopenia should receive empirical antistaphylococcal therapy be-
cause of the strong association between baseline thrombocytopenia
and Staphylococcus aureus infection. Second, if antiplatelet agents
are being considered as adjunctive therapy (4), clinicians should
exclude coexistent thrombocytopenia because of its potential to
increase the risk of bleeding. Third, thrombocytopenia at day 8
indicates an impaired host response to sepsis and predicts increased
mortality. In this setting, patients with thrombocytopenia may
warrant more intensive monitoring, alterations to treatment, and,
where relevant, consideration of surgery.
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For a supplementary figure and tables, please see the online version of
this paper.
Letters to the Editor
Perioperative Myocardial
Infarction Has Been Forgotten
Thygesen et al. (1) have published a consensus report that reviews
the definition of myocardial infarction (MI) and proposes a new
classification of 5 categories based on differences in pathophysiol-
ogy. We believe that this definition is flawed in 1 respect: it does
not mention perioperative MI. This is not the first time that a MI
definition has been questioned. When the consensus document of
the Joint European Society of Cardiology/American College of
Cardiology redefinition of MI was released, Tunstall-Pedoe (2)
Figure 1 Severity of Thrombocytopenia
Is Associated With 6-Month Mortality
Six-month mortality in relation to platelet count at day 1 (A) and at day 8 (B).
The total number of patients within each band of platelet counts is indicated
by n. Chi-square test for trend p  0.001 at day 1 and day 8.
1825JACC Vol. 51, No. 18, 2008 Correspondence
May 6, 2008:1824–8
